Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Single Cell Multiomics Market Report by Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics), Product Type (Consumables, Instruments, Software), Technique (Single-Cell Isolation and Dispensing, Single-Cell Analysis), Application (Oncology, Cell Biology, Neurology, and Others), End User (Academic Institutes, Contract Research Organizations, Pharmaceutical and Biotech Companies), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A4907
Buy Now
Market Overview:
The global single cell multiomics market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 15.4% during 2024-2032.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023
|
|
Forecast Years
|
2024-2032
|
|
Historical Years
|
2018-2023
|
|
Market Size in 2023
|
US$ 4.0 Billion |
|
Market Forecast in 2032
|
US$ 15.0 Billion |
| Market Growth Rate 2024-2032 | 15.4% |
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
Single Cell Multiomics Market Trends:
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product type, technique, application and end user.
Breakup by Type:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information about this market, Request Sample
- Single Cell Genomics
- Single Cell Proteomics
- Single Cell Transcriptomics
- Single Cell Metabolomics
Breakup by Product Type:
- Consumables
- Instruments
- Software
Breakup by Technique:
- Single-Cell Isolation and Dispensing
- Single-Cell Analysis
Breakup by Application:
- Oncology
- Cell Biology
- Neurology
- Others
Breakup by End User:
- Academic Institutes
- Contract Research Organizations
- Pharmaceutical and Biotech Companies
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | US$ Billion |
| Segment Coverage | Type, Product Type, Technique, Application, End User, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc. |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global single cell multiomics market was valued at US$ 4.0 Billion in 2023.
We expect the global single cell multiomics market to exhibit a CAGR of 15.4% during 2024-2032.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of single-cell multiomics analysis for early diagnosis of the coronavirus infection among population.
The increasing demand of single cell multiomics for personalized medicine and solutions for screening and diagnosing genetic disorders and cell heterogeneity in the micro-environment, is primarily driving the global single cell multiomics market.
Based on the type, the global single cell multiomics market can be segmented into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. Currently, single cell genomics hold the majority of the total market share.
Based on the product type, the global single cell multiomics market has been divided into consumables, instruments, and software. Among these, consumables currently exhibit a clear dominance in the market.
Based on the technique, the global single cell multiomics market can be categorized into single-cell isolation and dispensing and single-cell analysis. Currently, single-cell isolation and dispensing holds the largest market share.
Based on the application, the global single cell multiomics market has been segregated into oncology, cell biology, neurology, and others, where oncology currently exhibits a clear dominance in the market.
Based on the end user, the global single cell multiomics market can be bifurcated into academic institutes, contract research organizations, and pharmaceutical and biotech companies. Currently, academic institutes account for the majority of the global market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global single cell multiomics market include 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings), and Thermo Fisher Scientific Inc.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More